Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04636918
What this trial is testing

Ikervis for DED Due to GVHD Post Allo-HSCT

Who this might be right for
Leukemia (Both ALL and AML)MDS-EB-1
Singapore Eye Research Institute 40
Testing effectiveness (Phase 2)UnknownNCT05808985
What this trial is testing

Intestinal Microbiome-based Research for the Prevention of Acute GVHD

Who this might be right for
Graft Versus Host DiseasePostbioticsButyrate
Soonchunhyang University Hospital 15
Not applicableStudy completedNCT01758250
What this trial is testing

Microvascular and Fibrosis Imaging Study

Who this might be right for
Autoimmune DiseasesSickle Cell DiseaseChronic Graft Versus Host Disease
Duke University 63
Not applicableActive Not RecruitingNCT05690971
What this trial is testing

Psychosocial Mobile App for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-Versus-Host DiseaseAllogeneic Stem Cell Transplant
Massachusetts General Hospital 120
Not applicableStudy completedNCT02409134
What this trial is testing

Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

Who this might be right for
Quality of LifeGraft-vs-Host Disease
Sung Choi, M.D. 9
Not applicableStudy completedNCT06736743
What this trial is testing

Review of Infant Oral Feeding and Skills

Who this might be right for
Nutrition DisordersGastrointestinal DiseaseDeglutition Disorder+12 more
Wake Forest University Health Sciences 108
Large-scale testing (Phase 3)Looking for participantsNCT05157685
What this trial is testing

Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults

Who this might be right for
Sinusitis, ChronicSinus Infection Chronic
Centre Hospitalier Intercommunal Creteil 230
Not applicableEnded earlyNCT01775735
What this trial is testing

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Who this might be right for
Migraine Disorders
Boston Scientific Corporation 28
Not applicableStudy completedNCT00422838
What this trial is testing

Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.

Who this might be right for
Hepatitis CLiverImmunology+1 more
Foundation for Liver Research 20
Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing

Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45
Testing effectiveness (Phase 2)Study completedNCT01790568
What this trial is testing

Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsNon-Neoplastic Hematologic and Lymphocytic Disorder
University of Michigan Rogel Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04944043
What this trial is testing

TQ05105 in Patients With Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 45
Large-scale testing (Phase 3)UnknownNCT05158608
What this trial is testing

Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis

Who this might be right for
Graft Versus Host DiseaseHematologic MalignancyCyclophosphamide Adverse Reaction
National Research Center for Hematology, Russia 100
Testing effectiveness (Phase 2)Looking for participantsNCT07570745
What this trial is testing

Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

Who this might be right for
Graft-Versus-Host Disease(GVHD)Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 82
Not applicableUnknownNCT06335277
What this trial is testing

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Who this might be right for
LeukemiaLeukemia, ChronicLeukemia, Acute+2 more
European Institute of Oncology 50
Testing effectiveness (Phase 2)UnknownNCT04971551
What this trial is testing

Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Who this might be right for
Acute Graft-Versus-Host Disease
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Testing effectiveness (Phase 2)Ended earlyNCT01204502
What this trial is testing

Suicide Gene Therapy Trial

Who this might be right for
Haploidentical Stem Cell Transplantation
Great Ormond Street Hospital for Children NHS Foundation Trust 2
Not applicableStudy completedNCT00340951
What this trial is testing

Can Immune Parameters Predict Acute and Chronic Rejection in Lung Recipients?

Who this might be right for
Lung Transplantation
National Institute of Environmental Health Sciences (NIEHS) 400
Testing effectiveness (Phase 2)Study completedNCT03613727
What this trial is testing

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Lymphoid LeukemiaMyeloid LeukemiaMonocytic Leukemia+1 more
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Next Page